Eventide Asset Management, LLC
About Eventide Asset Management, LLC’s 13F portfolio
Eventide Asset Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Eventide Asset Management, LLC reported $7.5B across 301 US-listed positions (). Its largest position is GUARDANT HEALTH INC (GH) at 3.9% of the reported book, and its ten biggest holdings make up 24% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: GH GUARDANT HEALTH INC | — — | 3.9% | 2.0M | $293.8M |
| 2 | NASDAQ: LRCX LAM RESEARCH CORP | — — | 3.9% | 673K | $291.7M |
| 3 | NASDAQ: XMTR XOMETRY INC | — — | 2.8% | 2.2M | $208.4M |
| 4 | NYSE: TT TRANE TECHNOLOGIES PLC | — — | 2.7% | 415K | $203.5M |
| 5 | NASDAQ: MIRM MIRUM PHARMACEUTICALS INC | — — | 2.0% | 1.2M | $146.2M |
| 6 | NASDAQ: ASML ASML HLDG NV | — — | 1.8% | 68K | $136.0M |
| 7 | NYSE: TRGP TARGA RES CORP | — — | 1.8% | 491K | $131.7M |
| 8 | NASDAQ: ODFL OLD DOMINION FREIGHT LINE IN | — — | 1.7% | 599K | $129.9M |
| 9 | NYSE: GEV GE VERNOVA INC | — — | 1.7% | 107K | $124.7M |
| 10 | NYSE: URI UNITED RENTALS INC | — — | 1.6% | 103K | $117.2M |
| 11 | NASDAQ: ARGX ARGENX SE | — — | 1.6% | 126K | $116.6M |
| 12 | NASDAQ: SRRK SCHOLAR ROCK HLDG CORP | — — | 1.6% | 2.1M | $116.1M |
| 13 | NASDAQ: IRTC IRHYTHM HOLDINGS INC | — — | 1.4% | 880K | $104.7M |
| 14 | NASDAQ: KLAC KLA CORP | — — | 1.3% | 339K | $100.9M |
| 15 | NASDAQ: BBNX BETA BIONICS INC | — — | 1.3% | 6.3M | $98.1M |
| 16 | NASDAQ: LSCC LATTICE SEMICONDUCTOR CORP | — — | 1.2% | 611K | $93.5M |
| 17 | NYSE: NVT NVENT ELEC PLC | — — | 1.2% | 536K | $90.6M |
| 18 | NYSE: GNRC GENERAC HLDGS INC | — — | 1.2% | 307K | $89.8M |
| 19 | NASDAQ: DDOG DATADOG INC | — — | 1.2% | 342K | $89.0M |
| 20 | NASDAQ: PANW PALO ALTO NETWORKS INC | — — | 1.1% | 252K | $85.7M |
| 21 | NYSE: ETR ENTERGY CORP NEW | — — | 1.1% | 728K | $83.9M |
| 22 | NASDAQ: PCVX VAXCYTE INC | — — | 1.1% | 1.4M | $80.2M |
| 23 | NASDAQ: MPWR MONOLITHIC PWR SYS INC | — — | 1.1% | 58K | $79.7M |
| 24 | NYSE: VST VISTRA CORP | — — | 1.1% | 499K | $79.4M |
| 25 | NYSE: DELL DELL TECHNOLOGIES INC | — — | 1.1% | 186K | $79.3M |
Showing 1–25 of 301 positions on this page reported in this 13F.
- Healthcare35%
- Technology23%
- Industrials20%
- Energy5.5%
- Consumer Cyclical4.2%
- Utilities4.1%
- Financial Services3.3%
- Basic Materials2.2%
- Real Estate0.7%
- Consumer Defensive0.0%
- Communication Services0.0%
- AddedTTTRANE TECHNOLOGIES PLC+2.1%$203.5M
- AddedASMLASML HLDG NV+0.4%$136.0M
- AddedODFLOLD DOMINION FREIGHT LINE IN+1.3%$129.9M
- AddedURIUNITED RENTALS INC+5.8%$117.2M
- AddedARGXARGENX SE+0.0%$116.6M
- AddedIRTCIRHYTHM HOLDINGS INC+15.7%$104.7M
- AddedKLACKLA CORP+756%$100.9M
- AddedBBNXBETA BIONICS INC+5.2%$98.1M
- AddedLSCCLATTICE SEMICONDUCTOR CORP+0.0%$93.5M
- AddedNVTNVENT ELEC PLC+2.4%$90.6M
- ReducedGHGUARDANT HEALTH INC−17.1%$293.8M
- ReducedLRCXLAM RESEARCH CORP−2.2%$291.7M
- ReducedXMTRXOMETRY INC−27.3%$208.4M
- ReducedMIRMMIRUM PHARMACEUTICALS INC−11.4%$146.2M
- ReducedTRGPTARGA RES CORP−2.3%$131.7M
- ReducedGEVGE VERNOVA INC−19.7%$124.7M
- ReducedSRRKSCHOLAR ROCK HLDG CORP−3.9%$116.1M
- ReducedPANWPALO ALTO NETWORKS INC−0.2%$85.7M
- ReducedMPWRMONOLITHIC PWR SYS INC−0.6%$79.7M
- ReducedAXSMAXSOME THERAPEUTICS INC.−39.0%$77.5M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | BBNX Beta Bionics, Inc. | 13G | 13.4% · 2 classes | 5.9M | Filed 15 MAY 2026 |
| 2 | XMTR Xometry, Inc. | 13G | 6.7% | 3.2M | Filed 14 FEB 2025 |
| 3 | OVID Ovid Therapeutics Inc. | 13G | 6.3% | 11.8M | Filed 14 AUG 2026 |
| 4 | IMMX Immix Biopharma, Inc. | 13G | 5.6% | 3.9M | Filed 14 AUG 2026 |
| 5 | ENGN enGene Therapeutics Inc | 13G | 5.1% | 3.4M | Filed 13 NOV 2026 |
Showing all 5 disclosed stakes. 1 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading Eventide Asset Management, LLC’s 13F portfolio
Eventide Asset Management, LLC’s $7.5B 13F book is spread across 301 reported positions and is broadly diversified — the ten largest names are just 24% of the portfolio. Spread this wide, no single position dominates the book. Its five largest positions are GH, LRCX, XMTR, TT and MIRM, led by GUARDANT HEALTH INC (GH) at 3.9% of the portfolio. The heaviest sector exposure is Healthcare (35%), then Technology (23%).
What Eventide Asset Management, LLC changed last quarter
Between 2026-03-31 and Q2 2026, Eventide Asset Management, LLC was a net buyer: it opened 60 new positions and added to 160 more, while trimming 68 and closing 37 outright. Against a 301-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was TRANE TECHNOLOGIES PLC (TT), and its biggest reduction was GUARDANT HEALTH INC (GH).
What a 13F does and doesn’t reveal
A 13F captures only Eventide Asset Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Eventide Asset Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Eventide Asset Management, LLC's profile on this page is built directly from those filings.
How current is the 13F data on Eventide Asset Management, LLC's page?
It reflects Eventide Asset Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Eventide Asset Management, LLC files its next quarterly report, this page refreshes automatically.
Can I see Eventide Asset Management, LLC's complete list of holdings?
This page highlights Eventide Asset Management, LLC's largest positions rather than all 301 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Eventide Asset Management, LLC's filings.
Does a 13F show everything Eventide Asset Management, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Eventide Asset Management, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Eventide Asset Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

